90%) for biotechnology 1.01656./>
1.01697

Benzonase® endonuclease

EMPROVE® EXPERT

Manufacturer: SAFC

CAS Number: 9025-65-4

Synonym(S): Endonuclease from Serratia marcescens

Select a Size

Pack Size SKU Availability Price
500 KU 1.01697-500-KU In Stock ₹ 3,92,583.69
5000 KU 1.01697-5000-KU In Stock ₹ 23,86,596.57

1.01697 - 500 KU

₹ 3,92,583.69

In Stock

Quantity

1

Base Price: ₹ 3,92,583.69

GST (18%): ₹ 70,665.064

Total Price: ₹ 4,63,248.754

biological source

Serratia marcescens

Quality Level

500

recombinant

expressed in E. coli

description

suitable for biopharmaceutical production EMPROVE® bio

product line

EMPROVE® EXPERT

Assay

≥99% (SDS-PAGE)

form

buffered aqueous glycerol solution

concentration

≥250 units/μL

pH

8.0 (25 °C in H2O)

application(s)

pharma/biopharma processes

Related Products

Img

SAFC

1.01695

suitable for biopharmaceutical prod...

Img

SAFC

1.01654

purity grade II (>90%) for biotechn...

Img

Millipore

E1014

≥250 units/μL, ≥90% (SDS-PAGE), rec...

Img

Millipore

71206

Purity > 99%, Effective Viscosity R...

Img

Millipore

70664

Purity > 99%, Effective viscosity r...

Img

Millipore

71205-M

Purity > 90%, Serratia marcescens, ...

Img

SAFC

1.01656

--

Description

  • General description: Benzonase® endonuclease acts as an unspecific endonuclease, degrading both DNA and RNA to small 3–5 base pairs (< 6 kDa) fragments with no base preference. It is the ideal tool for nucleic acid removal in virus vector and vaccine manufacturing as demanded by regulators. Additionally, the use of Benzonase® endonuclease increases the yield in virus purification, protects downstream chromatography and filter devices from fouling, and reduces feed stream viscosity.Benzonase® endonuclease is the smart solution for DNA removal in viral vaccine and viral vector production and has proven its value for over 30 years. Balancing efficiency and regulatory compliance by delivering reliability and high-quality due manufacturing under good manufacturing practices (GMP ICH Q7). Our extensive documentation packages of Emprove® dossiers and the availability of a FDA Drug Master File type II, supports you in filing your vaccine manufacturing process to the authorities.
  • Application: Used for the removal of nucleic acid from protein samples.
  • Biochem/physiol Actions: Digests native or heat-denatured DNA and RNA.
  • Analysis Note: Appearance (description): clearAppearance (color): colourlessActivity (DNA; pH 8.0; 30 min; 37 °C): ≥ 250 U/µlSpec. activity (calc. on protein): ≥ 1.1E+06 U/mgIdentity (electrophoresis): passes testPurity (calc. on protein): ≥ 99.0%Proteases: not detectableColony count (aerobic bacteria): <10 CFU in 100 000 UColony count (Yeasts and moulds): <10 CFU in 100 000 UEndotoxines (LAL-test): <0.25 EU in 1000 U
  • Legal Information: Benzonase is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

Storage Class Code

10 - Combustible liquids

WGK

WGK 1